1. Home
  2. SCYX vs NSTS Comparison

SCYX vs NSTS Comparison

Compare SCYX & NSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • NSTS
  • Stock Information
  • Founded
  • SCYX 1999
  • NSTS 1921
  • Country
  • SCYX United States
  • NSTS United States
  • Employees
  • SCYX N/A
  • NSTS N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • NSTS Savings Institutions
  • Sector
  • SCYX Health Care
  • NSTS Finance
  • Exchange
  • SCYX Nasdaq
  • NSTS Nasdaq
  • Market Cap
  • SCYX 50.3M
  • NSTS 59.1M
  • IPO Year
  • SCYX 2014
  • NSTS N/A
  • Fundamental
  • Price
  • SCYX $1.18
  • NSTS $11.20
  • Analyst Decision
  • SCYX Buy
  • NSTS
  • Analyst Count
  • SCYX 1
  • NSTS 0
  • Target Price
  • SCYX N/A
  • NSTS N/A
  • AVG Volume (30 Days)
  • SCYX 165.3K
  • NSTS 5.9K
  • Earning Date
  • SCYX 11-06-2024
  • NSTS 11-13-2024
  • Dividend Yield
  • SCYX N/A
  • NSTS N/A
  • EPS Growth
  • SCYX N/A
  • NSTS N/A
  • EPS
  • SCYX N/A
  • NSTS N/A
  • Revenue
  • SCYX $8,566,000.00
  • NSTS $6,187,000.00
  • Revenue This Year
  • SCYX N/A
  • NSTS N/A
  • Revenue Next Year
  • SCYX $145.59
  • NSTS N/A
  • P/E Ratio
  • SCYX N/A
  • NSTS N/A
  • Revenue Growth
  • SCYX N/A
  • NSTS N/A
  • 52 Week Low
  • SCYX $1.15
  • NSTS $8.57
  • 52 Week High
  • SCYX $3.07
  • NSTS $11.50
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 28.95
  • NSTS 60.19
  • Support Level
  • SCYX $1.25
  • NSTS $11.10
  • Resistance Level
  • SCYX $1.37
  • NSTS $11.22
  • Average True Range (ATR)
  • SCYX 0.06
  • NSTS 0.08
  • MACD
  • SCYX -0.01
  • NSTS -0.01
  • Stochastic Oscillator
  • SCYX 9.26
  • NSTS 100.00

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About NSTS NSTS Bancorp Inc.

NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in our market area of Lake County, Illinois and adjacent communities.

Share on Social Networks: